Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Suvorexant

Suvorexant

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Suvorexant

25 trials tracked of Suvorexant: 15 in phase 3 or 4 and 4 with published results. The most-cited published study has 27 citations.

25Trials tracked
15Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 12 Phase 3 3 Phase 2 3 Phase 1 6 Other / NA 1
  1. Phase 3 Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085) Completed · 27 cited
  2. Phase 4 Suvorexant and Trauma Related Insomnia Completed · 25 cited
  3. Phase 4 Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia Completed · 21 cited
  4. Phase 4 Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia Completed · 4 cited
  5. Phase 4 Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder Completed
  6. Phase 4 Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes Completed
Show 19 more trials
  1. Phase 4 Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder Completed
  2. Phase 4 A Pilot Study of Suvorexant for Insomnia in Parkinson Disease Completed
  3. Phase 4 A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia Completed
  4. Phase 4 Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia Completed
  5. Phase 4 The Role of Orexin in Human Panic Disorder Completed
  6. Phase 4 To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia Completed
  7. Phase 4 Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers Completed
  8. Phase 3 Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061) Completed
  9. Phase 3 A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3) Completed
  10. Phase 2 Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006) Completed
  11. Phase 2 Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use Completed
  12. Phase 2 Suvorexant for Opioid/Stimulant Co-use Completed
  13. Phase 1 Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032) Completed
  14. Phase 1 Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036) Completed
  15. Phase 1 Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder Completed
  16. Phase 1 Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017) Completed
  17. Phase 1 Suvorexant and Cocaine Completed
  18. Phase 1 Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED) Completed
  19. N/A Sleep Quality and Amyloid-Beta Kinetics Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.